Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DESIPRAMINE for Mantle cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where DESIPRAMINE was used for Mantle cell lymphoma.

Most Reported Side Effects for DESIPRAMINE

Side Effect Reports % Deaths Hosp.
Completed suicide 85 20.0% 85 20
Toxicity to various agents 55 12.9% 53 9
Weight increased 48 11.3% 0 1
Drug hypersensitivity 43 10.1% 0 1
Drug ineffective 43 10.1% 0 11
Therapy non-responder 41 9.6% 0 0
Immune thrombocytopenia 37 8.7% 0 0
Acute kidney injury 26 6.1% 0 21
Loss of consciousness 24 5.6% 15 3
Off label use 22 5.2% 7 7
Overdose 21 4.9% 15 6
Urinary retention 21 4.9% 0 18
Intestinal obstruction 19 4.5% 0 17
Drug interaction 18 4.2% 13 1
Cardio-respiratory arrest 17 4.0% 17 7

Other Indications for DESIPRAMINE

Product used for unknown indication (173) Complex regional pain syndrome (41) Depression (25) Schizoaffective disorder (13) Antidepressant therapy (5) Bipolar disorder (5) Irritable bowel syndrome (5) Neuralgia (5)

Other Drugs Used for Mantle cell lymphoma

IBRUTINIB (6,306) RITUXIMAB (3,940) LENALIDOMIDE (2,989) CYCLOPHOSPHAMIDE (1,815) DOXORUBICIN (1,396) VENETOCLAX (1,367) VINCRISTINE (1,361) BENDAMUSTINE (1,227) CYTARABINE (1,174) DEXAMETHASONE (949)

Related Pages

DESIPRAMINE Full Profile All Mantle cell lymphoma Drugs DESIPRAMINE Demographics DESIPRAMINE Timeline